Author

K. M. Dobos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Andama· 1 shared A. Brandl· 1 shared A. M. Peev· 1 shared A. Nilsen· 1 shared A. Pinter· 1 shared C. McMurtrey· 1 shared C. Sundling· 1 shared C. T. Boughter· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Andama

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells

H. Jin, N. A. Ladd, A. M. Peev, G. M. Swarbrick, M. Cansler, M. Null, C. T. Boughter, C. McMurtrey, A. Nilsen, K. M. Dobos, W. H. Hildebrand, D. A. Lewinsohn, E. J. Adams, D. M. Lewinsohn, M. Harriff

This study modifies MR1 ligands to assess their impact on MR1-restricted T cell activation, revealing variable IFN-gamma responses and structural dynamics influencing recognition.

bioRxiv · May 11, 2022Immunology

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

J. L. Cantera, L. M. Lillis, R. B. Peck, E. Moreau, J. A. Schouten, P. Davis, P. K. Drain, A. Andama, A. Pinter, M. Kawasaki, G. Kallenius, C. Sundling, K. M. Dobos, D. Flores, D. Chatterjee, , D. S. Boyle

This study evaluates new LAM-specific antibodies for TB diagnosis, finding that while some show strong binding to cultured LAM, their performance with urinary LAM varies, and no new antibodies outperform existing ones in clinical samples.

bioRxiv · Apr 12, 2022Microbiology

A Dose-Response Model and D10-Value for Mycobacterium tuberculosis Exposed to Dosimetrically Verified Ionizing Radiation

J. V. Watkins, J. Bell, P. Knabenbauer, A. Brandl, K. M. Dobos

This study develops a dose-response model and D10-value for Mycobacterium tuberculosis exposed to ionizing radiation, providing a biological baseline for inactivation verification.

bioRxiv · Mar 2, 2021 · PreprintMicrobiology